Establishing an upper level of intake for vitamin A in Atlantic salmon (Salmo salar L.) postsmolts

The vitamin A (VA) concentration in salmon aquaculture feeds is varying and may lead to sublethal adverse effects. In this study, 135 g Atlantic salmon postsmolts were given eight diets in duplicates with 6, 12, 26, 55, 82, 112, 360 and 749 mg retinol (ROL) kg⁻¹ for 116 days. Subsequently, fish given 6, 82 and 749 mg ROL kg⁻¹ were transferred to a common net pen and given a standard commercial diet for further 28 weeks. Feed conversion rate, liver functionality and markers of VA homoeostasis were not negatively affected by dietary VA level, but chronic high VA intakes led to adverse effects on growth and bone health. In plasma, there was an antagonistic effect of dietary ROL on circulating 1,25 (OH)₂ vitamin D₃ (calcitriol). Moreover, a dose–response of VA on craniofacial deformities, condition factor and vertebral morphometry and mechanical strength was observed. Vertebral deformities were observed after 28 weeks on a standard diet and not immediately after the 116 days on the experimental diet. Elevated VA is a risk factor for bone deformities, and the dietary intake of VA should not exceed 37 mg ROL kg⁻¹ body weight day⁻¹ in Atlantic salmon postsmolts.     

Dietary vitamin A requirements of juvenile Japanese flounder Paralichthys olivaceus

A 70‐day feeding experiment was conducted to assess the dietary vitamin A (VA) requirements of juvenile Japanese flounder (Paralichthys olivaceus). Six semi‐purified diets with VA supplementations of 0, 5000, 10 000, 15 000, 20 000 and 25 000 IU kg^?1 were fed twice a day to triplicate groups of 20 juveniles per tank with an initial weight of 1.59 ± 0.01 g (mean ± SE). Weight gain (WG) and specific growth rate (SGR) increased as dietary VA increased up to 10 000 IU kg^?1. Significantly lower WG and SGR were observed for the 0 IU kg^?1 treatment than for treatments of 5000, 10 000 and 15 000 IU kg^?1. Highest WG and SGR were observed in fish fed 10 000 IU kg^?1; slightly lower values were recorded in fish fed 15 000, 20 000 or 25 000 IU kg¹. No significant difference was observed in survival rate among treatments. Whole body total lipid was significantly higher in fish fed 0 and 5000 IU kg^?1 than for other levels. Reduced growth and small livers were observed as signs of VA deficiency in fish fed 0 IU kg^?1. Slightly reduced growth and pale fragile livers were observed as effects of VA excess in fish fed 25 000 IU kg^?1. Total retinol contents in liver and eyes increased with increasing levels of dietary VA. No retinol was detected in livers, and significantly lower total retinol content was observed in eyes, of fish fed 0 IU kg^?1. WG analysed by the broken line method indicated that an optimum dietary VA requirement of 9000 IU kg^?1.     

Growth and survival of Atlantic salmon, Salmo salar L. fed different dietary levels of astaxanthin. Juveniles

Atlantic salmon, Salmo salar L., juveniles, with a mean initial weight of 1.75 g, were fed casein-based purified diets which had been supplemented with different levels of astaxanthin for a 10-week period. The astaxanthin content of the diets ranged from 0 to 190 mg kg^?1 dry diet. The growth and survival of the juveniles were recorded throughout the experiment. The proximate composition, astaxanthin and vitamin A content were determined from whole-body samples at the start and termination of the experiment. The dietary treatment was found to affect growth significantly (P < 0.05). A reduction in the mean weight of the juveniles was observed in the groups fed the diets without astaxanthin supplementation. There was no difference in growth rate between the fish in the groups fed the diets containing 36 or 190 mg astaxanthin kg^?1 dry diet, whereas the fish in the group fed the diet containing 5.3 mg astaxanthin kg^?1 dry diet had a lower growth rate. There was a tendency to higher survival in the groups fed the diets containing astaxanthin when compared with the groups fed the non-supplemented diets. The moisture and ash contents were significantly lower and the lipid content was higher in the groups fed the astaxanthin-supplemented diets. The astaxanthin and the vitamin A concentrations in the fish were found to be dependent upon the dietary astaxanthin dose; the highest values were found in the fish fed the diet with the highest astaxanthin content. These results strongly indicate that astaxanthin functions as a provitamin A for juvenile Atlantic salmon. The body storage of vitamin A increased in the fish fed the diets containing astaxanthin. However, the increase was low in the fish fed the diet containing 5.3 mg astaxanthin kg^?1 dry diet.     

The effect of dietary vitamin A on the immunocompetence of Atlantic salmon (Salmo salar L.)

Atlantic salmon, Salmo salar L. were maintained on diets containing low (0.37 mg kg^–1 diet), normal (1.95 mg kg^–1 diet) and high (15 mg kg^–1 diet) levels of vitamin A fed at 1.5% body weight per day. After 4 months, liver vitamin A levels reflected dietary intake and growth rates of all three groups were similar. Kidney leucocyte migration and serum bactericidal activity were found to be significantly reduced in fish fed low levels of vitamin A. On the other hand, high levels of vitamin A in the diet were found to augment serum antiprotease activity relative to the levels found in the other dietary groups. However, phagocyte respiratory burst activity, bactericidal activity and eicosanoid production were unaffected by the dietary vitamin A regime, as were lymphocyte functions (lymphokine and antibody production) and both serum lysozyme and classical complement activity. That the overall immunomodulatory effect of vitamin A was small was reflected in the resistance to Aeromonas salmonicida. No significant differences were found between the different vitamin A intake groups despite a trend to decreased resistance in the low vitamin A diet group.     

Astaxanthin deposition in fillets of Atlantic salmon Salmo salar L. fed two dietary levels of astaxanthin in combination with three levels of α-tocopheryl acetate

The influence of α-tocopheryl acetate (α-TOAc) on plasma concentration and fillet deposition of dietary astaxanthin was investigated in Atlantic salmon Salmo salar L. The diets were added 30 or 50 mg kg^–1 astaxanthin, and 200, 400 or 800 mg kg^–1α-TOAc at each astaxanthin level. Improved flesh deposition of astaxanthin by 8–14% was achieved for fish fed diets with 30 and 50 mg kg^–1 astaxanthin, respectively, by the dietary addition of 800 compared with 200 mg kg^–1α-TOAc. These results were supported by CIE[1976]L*a*b* tristimulus redness measurements (a* value). Plasma astaxanthin concentration mirrored the muscle astaxanthin concentration in the groups of fish fed a diet containing 30 mg kg^–1 astaxanthin. The salmon fed a high astaxanthin and low α-TOAc diet had the highest plasma concentration of idoxanthin (P < 0.05). Astaxanthin retention was significantly higher (P < 0.001) in salmon fed 30 mg kg^–1 astaxanthin than in those fed 50 mg kg^–1 astaxanthin, but was not significantly affected by dietary α-TOAc. Liver weight, body weight, specific growth rate, feed/gain ratio and mortalities were not affected by dietary α-TOAc levels. In conclusion, the dietary addition of α-TOAc appears to increase astaxanthin fillet deposition in salmonids and may reduce the demand for astaxanthin supplementation. The effect was rather small and requires verification.     

Antioxidant vitamins, minerals and lipid levels in diets for Atlantic salmon (Salmo salar, L.): effects on growth performance and fillet quality

An experiment with 2^{(7 ? 3)} reduced factorial design was conducted to study the biological effects of pro‐ and antioxidant micronutrients and lipid in Atlantic salmon. Vitamins C and E, astaxanthin, lipid, iron, copper and manganese were supplemented at high and low levels. For vitamins and minerals, high levels were chosen to be below the anticipated toxic level and the low levels were just above the requirement (vitamin C, 30 and 1000 mg kg^?1; vitamin E, 70 and 430 mg kg^?1; Fe, 70 and 1200 mg kg^?1; Cu, 8 and 110 mg kg^?1; Mn, 12 and 200 mg kg^?1). For astaxanthin, the dietary levels were 10 and 50 mg kg^?1 and for lipid, 150 and 330 g kg^?1. The experiment was started with postsmolts (148 ± 17 g) and lasted for 5 months. The variation in micronutrients had only minor effects on growth, feed conversion and fillet quality, measured as lipid and astaxanthin deposition. High dietary lipid had a profound positive effect on growth and feed conversion but gave fillets nearly two times the fat content that was found in fish fed the low lipid diet. Astaxanthin deposition in the fillet was primarily affected by dietary astaxanthin with a positive effect of high dietary lipid in week 14 but not in week 23. Vitamin E protected the fillet against iron ascorbate stimulated oxidation, with no effect of the other nutrient variables.     

Growth and survival of Atlantic salmon, Salmo salar L., fed different dietary levels of astaxanthin. First-feeding fry

Atlantic salmon fry hatched from pigment-free eggs and from eggs containing the pigment astaxanthin were fed eleven casein/gelatine-based purified diets with varying levels of astaxanthin, ranging from 0 to 317 mg kg^?1, to determine the optimum dietary astaxanthin level for satisfactory growth and survival during the start-feeding period. The fish were fed the experimental diets for a period of 11 weeks. No difference in performance was found between the two types of fry originating from the pigment-free eggs and those containing pigment. However, the dietary astaxanthin concentration was found to have a significant effect on both the growth and the survival of fry. Fish fed diets with astaxanthin concentrations below 5.3 mg kg^?1 were found to have marginal growth. In addition, mortality was high in the groups fed diets with astaxanthin concentrations below 1.0 mg kg^?1. The specific growth rate (SGR) was also affected by the dietary treatment. The lipid content was higher and the moisture content was lower in the fish fed the diets containing astaxanthin concentrations above 5.3 mg kg^?1. The vitamin A and astaxanthin concentrations in whole-body samples of the fry were significantly affected by the dietary level of astaxanthin. A plateau level in whole-body vitamin A concentration was observed at dietary levels of approximately 80 mg astaxanthin kg^?1 and higher, while no maximum astaxanthin concentration in whole-body samples was observed within the dietary levels used. The results suggest the need for a minimum dietary astaxanthin concentration of 5.1 mg kg^?1 to achieve maximum growth and survival during the start-feeding period. The results indicate a low bioavailability of vitamin A palmitate and acetate and the results also suggest a provitamin A function for astaxanthin during the same period.     

The effect of vitamin E on growth, survival and hepatopancreas structure of the Argentine red shrimp Pleoticus muelleri Bate (Crustacea, Penaeidea)

Two trials were conducted to evaluate the growth, survival and hepatopancreas histology of the Argentine red shrimp Pleoticus muelleri (Bate, 1888) fed different levels of vitamin E and butylated hydroxytoluene (BHT) in a semipurified diet. The diets contained 0, 100, 600 or 1500 mg vitamin E kg^?1 and 16 mg BHT kg^?1 diet (trial 1) and 0, 1250, 1500, 1750 or 2000 mg vitamin E kg^?1 diet, squid mantle and vitamin‐free diet as a control (trial 2). After 30 days (trial 1), survival ranged between 43% and 64%, and the percentage weight gain of the shrimp varied from 22% to 31% with no significant differences among treatments (P<0.05). After 40 days (trial 2), survival of shrimp fed the diet with no vitamin E and squid mantle was significantly lower (62%) than the other treatment (86–90%). Shrimp fed diets containing vitamin E from 1250 to 1750 mg kg^?1 exhibited increased weight gain (34–65%); however, a significant difference was observed for shrimp fed the diet containing 2000 mg kg^?1. Histological results yielded differences among treatments. In shrimp fed 1750 mg kg^?1 of vitamin E, the functional morphology of the organ was normal, with abundant secretion in the tubules. Signs of malnourishment such as cellular and nuclear retraction, desquamation of cells and hipertrofia, were evident in the hepatopancreas of shrimp fed the other diets. The results indicate that optimal vitamin E requirement for P. muelleri under the present experimental conditions appears to be approximately 1750 mg vitamin E kg^?1 diet.     

Astaxanthin deposition in the flesh of Atlantic Salmon, Salmo salar L., in relation to dietary astaxanthin concentration and feeding period

Atlantic salmon, Salmo salar L., were fed nine experimental diets containing from 0 to 200 mg astaxanthin per kg^?1 for six time periods, ranging from 3 to 21 months, in sea cages at Matre Aquaculture Research Station, Matredal, Norway. The sampled fish had an initial mean weight of 115 g and reached a weight of 3.2 kg at the termination of the experiment. Every third month, 10 fish from each dose and time group were sampled and the astaxanthin concentration in the flesh determined. The amount of astaxanthin in the flesh ranged from 0.7 to 8.9 mg kg^?1 at the termination of the experiment. This paper discusses deposition of astaxanthin in the flesh of Atlantic salmon in relation to dietary carotenoid levels in the 0–200 mg kg^?1 range and feeding times of 3–21 months. Under the conditions of this experiment, no significant effect on astaxanthin deposition rate could be achieved by increasing the astaxanthin level above 60 mg kg dry feed^?1. Atlantic salmon should be fed astaxanthin-supplemented diets during the whole seawater stage in order to obtain maximal astaxanthin level in the flesh.     

Influence of dietary menadione nicotinamide bisulphite (vitamin K3) and phylloquinone (vitamin K1) on Atlantic salmon (Salmo salar L.) tissue levels,determined by high‐performance liquid chromatography with fluorescence detection

The aim of the present study was to investigate the retention of menadione nicotinamide bisulphite (MNB; vitamin K₃) and phylloquinone (vitamin K₁) in Atlantic salmon (Salmo salar L.). Another objective was to find a reliable method for determination of menadione in fish feed, and to include and validate more matrices in the methods for phylloquinone and menaquinones (vitamin K₂). Duplicate tanks of Atlantic salmon (～93 g) were fed four levels (0–1000 mg menadione kg^?1 feed) of MNB for 9 weeks. The concentration of menadione and phylloquinone in the feed and the concentration of phylloquinone and menaquinone‐4 (MK‐4) in the tissues were determined. The analysed concentration of dietary menadione found in feed indicated a substantial loss of MNB during feed production. This assumption was supported by screening 15 commercial fish feed samples which also revealed menadione concentrations far below the recommended level. MNB fed salmon showed only a minor increase in liver MK‐4 concentration, compared to salmon fed phylloquinone which had a considerably higher level of liver phylloquinone, indicating a higher retention of phylloquinone compared to menadione in Atlantic salmon. Due to highly varying stability and bioavailability of the different vitamin K derivatives, vitamin K supplementation in fish feed needs a revision.     

Determination of the threonine requirement for maintenance in Atlantic salmon (Salmo salar L.) fry with the diet dilution procedure

A study was conducted to evaluate the threonine (Thr) requirement for maintenance in Atlantic salmon using the diet dilution procedure (DDP). Fourteen groups of 60 salmon fry [1.46 g initial body weight (BW)] were fed on seven semi‐purified diets containing graded levels of N (3–64 g kg⁻¹ dry matter) and L‐Thr (1–39 g kg⁻¹ dry matter). Seven doses of Thr represented 1–31% of its ideal level for optimum protein deposition. Indispensable amino acids (AA) other than Thr were included in the same proportion as in the Atlantic salmon fry whole‐body carcass. Protein deposition and Thr accretion were linear functions of Thr intake. At zero Thr intake fry lost 4.4 mg Thr kg BW^−0.75 day⁻¹ and the Thr requirement for maintenance was 5.8 mg kg BW^−0.75 day⁻¹, which represented 11% of the total need for Thr. Increasing doses of Thr did not show any effect on AA concentrations in whole‐body protein, except for cystine. The linear relationship between Thr gain and Thr intake indicates a constant Thr cumulative efficiency (77%) at marginal Thr intake. Finally, our results suggest that (1) both the DDP and the graded supplementation technique can be used in Atlantic salmon fry for the determination of AA maintenance requirement and utilization efficiency, at least for Thr; (2) the dietary protein level has only a minor effect on the Thr maintenance requirement determination.     

An estimation of dietary iron requirement of Atlantic salmon, Salmo salar L., parr

A study was conducted to determine the dietary iron requirement of fingerling Atlantic salmon Salmo salar L. During the first 4 weeks of the experiment, fish with an initial weight of 5 g were fed a casein–gelatine-based purified diet which contained 11 mg iron kg^?1. Thereafter duplicate tanks (200 fish in each) were fed the casein–gelatine purified diets containing supplemental iron levels of 0, 10, 20, 30, 40, 60, 100, 200 or 400 mg iron kg^?1 (added as FeSO_?4* 7H₂O) for 12 weeks. Weight gain, body length and mortality were monitored. Liver iron and ascorbic acid concentration were analysed in addition to whole-body iron, manganese and zinc concentration. Several haematological parameters were also measured. There were no significant differences in weight gain and survival of salmon fed diets containing different iron levels. Haematological values, hepatic and whole-body iron concentrations were, however, significantly affected by the dietary iron content. Liver vitamin C concentration decreased with increasing dietary iron levels. Dietary supplementation with iron significantly reduced whole-body manganese, but no effect of dietary iron on whole-body zinc was found. Based on haematology and hepatic iron concentration, the iron requirement of Atlantic salmon was determined to be between 60 and 100 mg iron kg¹.     

Growth, feed utilization and health of Atlantic salmon Salmo salar L. fed genetically modified compared to non-modified commercial hybrid soybeans

The present paper represents a part of a major scientific effort aiming to reveal possible effects, nutritional or health related, of genetically modified (GM) feed ingredients for Atlantic salmon. For 3 months groups of post‐smolt Atlantic salmon were treated with diets holding 130 g kg¹ of the protein as soybean, one which contained 800 g kg^?1 GM type RR (Roundup Ready^?), and compared with a standard counterpart (commercial hybrid, not isogenic line) analysed to be non‐GM (nGM), and again compared with a standard fishmeal diet without soybean protein. All diets were composed to be within the category ‘compositional equivalent’ and held exactly the same proximate compositions, starch and sugar levels, above requirements for methionine and lysine, equal fatty acid profiles, vitamin, mineral and pigment contents. There was, however, a slight difference in levels of anti‐nutrients between the three diets. The various dietary treatments resulted in more than tripling of fish weight in all groups. In addition no significant differences in feed utilization, whole body, liver and muscle proximate compositions, and no significant differences in muscle fatty acid profiles were measured. The diet without soybean of either type resulted in greater retention of lipid, but equal retention of protein (protein productive value). The relative sizes of liver, kidney, head–kidney and brain were the same in all dietary groups, while the relative size of the spleen showed significant differences between fish fed the genetically modified soy diet compared with fish fed the nGM soybeans. Fish fed the soy diets of either type also showed a somewhat reduced mean erythrocyte cell volume. All other haematological values were equal between diet groups. The detoxification system, measured as glutathione peroxidase (GPx) and lysozyme activities, showed equal values for all groups when measured in plasma and liver or head–kidney. The distal part of the intestine showed reduced sizes as an effect of soybean additions, without any differences between the GM and nGM type. Our results showed high growth, no mortality, haematological values within normal ranges, and efficient and equal responses in the detoxification system. This was a first indication that up to 130 g kg^?1 RR‐soybean protein can safely be used in diets for Atlantic salmon. However, there is still a need to elucidate higher inclusion levels of GM feed ingredients, and why spleen index was reduced, and if this was a long‐ or short‐term effect.     

Effects of various dietary factors on astaxanthin absorption in Atlantic salmon (Salmo salar)

The experiment was designed to investigate the dietary factors that might enhance or interfere with astaxanthin (Ax) absorption in salmon including potentially interfering factors such as certain carotenoids (zeaxanthin and lutein), plant sterols, fibre and enhancing compounds such as cholesterol and vitamin E. Two hundred and eighty‐eight salmon (778 ± 78 g) were reared in sea water under controlled conditions and fed practical experimental diets. The experimental diets were supplemented with 40 mg Ax kg^?1, in addition to various dietary factors, including cholesterol (2%), vitamin E (450 IU kg^?1), wheat bran (5%), lutein (40 mg kg^?1), zeaxanthin (40 mg kg^?1) and phytosterol (2%). After 26 days of feeding, blood was collected and plasma was separated to determine the plasma Ax concentration. Ax was not detected in the plasma of fish fed the non‐pigmented diet. Fish fed diet containing 2% cholesterol significantly improved Ax absorption, which was reflected in the higher Ax concentration in plasma of Atlantic salmon. Other supplements including vitamin E, wheat bran, lutein, zeaxanthin and phytosterols in diet had no significant effect on plasma Ax concentration . Fish fed diet containing 2% cholesterol significantly increased cholesterol concentration in fish plasma. Phytosterol had no benefit to lower cholesterol plasma level in fish fed 2% phytosterol‐supplemented diet.     

Fluoride retention of Atlantic salmon (Salmo salar) fed krill meal

The present experiment was performed to study how fluoride from krill meal enriched muscle, whole fish and bone of adult Atlantic salmon (Salmo salar) reared in sea water. Atlantic salmon (mean weight 0.5 kg) were divided into four triplicate groups and fed a commercial fish meal based diets with 0, 100, 200 and 300 g krill kg^?1 feed, respectively, for 12 weeks. The fluoride concentrations in the experimental feeds were analysed to be 18, 132, 235 and 358 mg kg^?1, respectively. Growth, mortality and feed efficiency were recorded through the experiment. Fluoride concentration was measured in muscle, whole‐body, and bone initially and after 12 weeks of feeding. The fluoride concentrations in the samples were determined by alkali fusion and fluoride ion‐selective electrode. Growth, mortality and feed efficiency ratio were not affected by the dietary treatments. The results showed that fluoride concentration in muscle, whole body and bone were not affected by the dietary fluoride level. The fluoride concentration in the tissues showed great variation among replicates of the group given the same diet. Fillets of the fish varied between 0.3 and 1.4 mg fluoride kg^?1 wet weight, whereas the whole‐body concentration of fluoride varied between 3.3 and 6.1 mg kg^?1 wet weight and the fluoride bone concentration varied between 5.8 and 7.2 mg kg^?1 fresh weight. These results suggest that Atlantic salmon are highly tolerant of dietary fluoride given as krill meal with concentration of fluoride up to 350 mg kg^?1 diet, and that accumulation of fluoride from feeding diets containing krill meal does not lead to tissue accumulation in the fish, at least over a short period of time.     

Efficacy of an equal blend of canola oil and poultry fat as an alternate dietary lipid source for Atlantic salmon (Salmo salar L.) in sea water. I: effects on growth performance, and whole body and fillet proximate and lipid composition

This study assessed the suitability and cost efficacy of an equal blend of canola oil (CO) and poultry fat (PF) as a supplemental dietary lipid source for juvenile Atlantic salmon. Quadruplicate groups of Atlantic salmon (～400 g) held in 4000 L outdoor fibreglass tanks supplied with running (35–40 L min^?1), aerated (dissolved oxygen, 7.88–10.4 mg L^?1), ambient temperature (8.6–10.9°C) sea water (salinity, 26–35 g L^?1) were fed twice daily to satiation one of three extruded dry pelleted diets of equivalent protein (488–493 g kg^?1 dry matter) and lipid (267–274 g kg^?1 dry matter) content for 84 days. The diets were identical in composition except for the supplemental lipid (234.7 g kg^?1) source viz., 100% anchovy oil (AO; diet COPF‐0), 70.2% AO and 29.8% CO and PF (diet COPF‐30), and 40.3% AO and 59.7% CO and PF (diet COPF‐60). Atlantic salmon growth rate, feed intake, feed efficiency, protein and gross energy utilization, percent survival and whole body and fillet proximate compositions were not affected by diet treatment. Cost per kilogram weight gain was about 10% less for fish fed diet COPF‐60 than for diet COPF‐0. Percentages of saturated fatty acids in dietary and fillet lipids varied narrowly. Moreover, percentages of 18:1n‐9, monounsaturated fatty acids, 18:2n‐6, n‐6 fatty acids, 18:3n‐3, and ratios of n‐6 to n‐3 fatty acids in the flesh lipids were directly related to the dietary level of CO and PF whereas 22:6n‐3, the total of 20:5n‐3 (eicosapentaenoic acid; EPA) and 22:6n‐3 (docosahexaenoic acid; DHA), and n‐3 fatty acids revealed the opposite trend. Percentages of 22:6n‐3, EPA and DHA, and n‐3 fatty acids were significantly depressed in fish fed diet COPF‐60 versus diet COPF‐0. We conclude that a 1:1 blend of CO and PF is an excellent cost‐effective dietary source of supplemental lipid for Atlantic salmon in sea water.     

Nutritive value of partially dehulled and extruded sunflower meal for post-smolt Atlantic salmon (Salmo salar L.) in sea water

This study determined the digestibility of protein in partially dehulled sunflower meal (SFM) and then, as the main goal, the nutritive value of high‐temperature extruded (≤149°C) partially dehulled SFM (SFM_EX) for post‐smolt Atlantic salmon Salmo salar in sea water. The digestibility study was conducted using the settling column approach (‘Guelph system’) for faeces collection as described by Hajen, Higgs, Beames and Dosanjh. In the nutritive value study, triplicate groups of 50 salmon (mean weight ～116 g) in 4000‐L outdoor fibreglass tanks supplied with 25–40 L min^?1, filtered, oxygenated (dissolved oxygen, 7.0–8.5 mg L^?1), 11–12°C sea water (salinity, 29–31 g L^?1), were fed twice daily to satiation one of five steam‐pelleted dry diets that contained 422 g of digestible protein (DP) kg^?1 and ～16.4 MJ of digestible energy (DE) kg^?1 on a dry weight basis for 84 days. Low‐temperature‐dried anchovy meal (LT‐AM) comprised 68.2% of the basal diet protein whereas in four test diets, SFM_EX progressively replaced up to 33.0% of the DP provided by LT‐AM in the basal diet (SFM_EX≤271 g kg^?1 of dry matter). Sunflower meal had 87.9% DP. Diet treatment did not significantly affect specific growth rate (1.39–1.45% day^?1), feed efficiency (1.19–1.26), percentage of dietary protein retained (45.8–47.5), gross energy utilization (46.5–49.4%), per cent survival (96.0–99.3) or terminal whole body and muscle proximate compositions. We conclude that SFM_EX can comprise ≥271 g kg^?1 of the dry diet or ≥22.7% of the digestible dietary protein of post‐smolt Atlantic salmon in seawater without any adverse effects on their performance.     

Bioavailability of oxytetracycline from medicated feed administered to Atlantic salmon (Salmo salar L.) in seawater

Bioavailability of oxytetracycline HCl was investigated in Atlantic salmon (Salmo salar L.) in seawater at 7–8 °C. A group of 80 fish received an intravascular injection of 20 mg kg⁻¹ body weight. Another group of about 90 fish were force-fed with medicated feed containing a dose of 50 mg kg⁻¹ body weight. The oral bioavailability was found to be only 2%.     

A preliminary study on tailoring of fillet iodine concentrations in adult Atlantic salmon (Salmo salar L.) through dietary supplementation

The present study was performed to assess to what degree supplemented dietary iodine (I) was retained in selected tissues, including the fillet of adult Atlantic salmon (Salmo salar) reared in sea water. Atlantic salmon weighing approximately 1.5 kg were randomly assigned to three net pens per treatment and fed moist pellets (based on minced saithe and herring) supplemented with 0, 40 or 80 mg iodine (as KI) kg^?1 on dry weight basis for 150 days. The iodine concentrations in the experimental feeds were analysed to be 10, 54 and 86 mg kg^?1 dry weight, respectively. Growth, mortality and blood haemoglobin concentration (Hb) were recorded. Iodine concentrations were measured in muscle, liver and kidney after 90 and 150 days of feeding by inductively coupled plasma‐mass spectrometry. In addition, plasma thyroxine (T₄) and triiodo‐thyronine (T₃) were determined. The weight gain during the period was approximately 1 kg for all treatments. There were no mortalities, and blood Hb levels were within normal ranges. The iodine concentration in muscle, liver and kidney were all affected by the dietary iodine level, despite wide intratreatment variation. After 150 days, fillets of fish fed 10, 54 and 86 mg I kg^?1 showed mean concentrations of 0.4, 0.5 and 0.9 mg I kg^?1 wet weight, respectively, whereas the iodine concentration in the liver and the kidney increased approximately three times in the dietary groups. Similarly, plasma T₄ and T₃ showed great variation within the treatments. No significant correlations were found between individual tissue iodine concentration and thyroid hormone concentration in any of the groups at any sampling time. This preliminary feeding experiment showed that fillet iodine in adult Atlantic salmon can be increased up to 1.4 mg I kg^?1 wet weight by dietary iodine 80 times the minimum requirement for salmonids, without impacting health, performance or plasma thyroid hormone status.